Tecnimede Group
Ana Simões has extensive experience in the field of medicinal chemistry, currently serving as a Specialist Chemistry Lab Technician at Tecnimede Group since June 2015, focusing on drug discovery and development projects. Prior to this role, Ana worked as a Researcher Trainee at Luzitin, S.A, where the synthesis of new chemical entities for cancer and dermatological treatments was a key responsibility. Ana's academic background includes a PhD in Medicinal Chemistry from Universidade de Coimbra, complemented by significant research work on porphyrins and photodynamic therapy during PhD studies at both Instituto de Ciências Nucleares Aplicadas à Saúde and CIC biomaGUNE. Additional experience includes roles as a Scientific Researcher and a Researcher at Universidade de Coimbra, contributing to projects aimed at pharmaceutical applications in oncology.
Tecnimede Group
1 followers
TECNIMEDE GROUP is composed by pharmaceutical companies of private and 100% Portuguese capital. Started its activity in 1980 and covers the entire life cycle of the medicinal products for human use: development, manufacture, promotion and marketing. TECNIMEDE GROUP's strategy is based on a strong investment in Research, Development and Production of Medicinal Products. It is intended that the results obtained allow to consolidate the Group's position in the Portuguese market and to strengthen exports and internationalization. Atlantic Pharma Brasil and Atlas Pharm (Morocco) are an example of the Group's expansion and development of manufacturing plants. The TECNIMEDE GROUP’s commercial activity is based on: - The solid positioning of the three commercial lines in Portugal; - The direct presence in Spain, Italy, Morocco, Colombia and Brazil; - The establishment of local partnerships in the more than 40 countries where it exports — almost all the European Union countries, as well as several countries in Africa, South America, North America, Asia and the Middle East. TECNIMEDE GROUP's portfolio includes more than 100 products, as a result of its R&D center, which results in more than 2,500 MAs worldwide. Our Mission is the "Improvement and preservation of human life and health through the development, production and marketing of pharmaceutical products with a strong focus on quality and technological innovation.